Patent details

EP2742051 Title: Amorpous form of the dolutegravir sodium salt

Basic Information

Publication number:
EP2742051
PCT Application Number:
PCT/IL/2012/050344
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP128314861
PCT Publication Number:
WO/2013/038407
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
Amorpous form of the dolutegravir sodium salt
French Title of Invention:
Forme amorphe du sel de sodium de dolutégravir
German Title of Invention:
Amorphe Form des Dolutegravir Natrium Salzes
SPC Number:

Dates

Filing date:
02/09/2012
Grant date:
12/10/2016
EP Publication Date:
12/10/2016
PCT Publication Date:
21/03/2013
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
18/06/2014
EP B1 Publication Date:
12/10/2016
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
02/09/2017
Expiration date:
02/09/2032
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
02/09/2012
 
 

Name:
Mapi Pharma Limited
Address:
16 Einstein Street Weizmann Science Park P.O. Box 4113, 74140 Ness Ziona, Israel (IL)

Inventor

1

Name:
MAROM Ehud
Address:
Israel (IL)

2

Name:
RUBNOV Shai
Address:
Israel (IL)

Priority

Priority Number:
201161534395
Priority Date:
14/09/2011
Priority Country:
United States (US)

Classification

Main IPC Class:
C07D 498/14;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages